SCHEMBL20174341

SCHEMBL20174341

c1ccc2c(c1)-c1ccc(-c3ccc(-c4cccc5cccnc45)cc3)cc1C21c2ccccc2-c2oc3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
BACE1 P56817 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
ATR Q13535 1/20 0.33
PDE4D Q08499 2/20 0.33
GRM4 Q14833 1/20 0.32
BRD4 O60885 1/20 0.32
PDK2 Q15119 2/20 0.32
ACVRL1 P37023 1/20 0.32
ACVR1 Q04771 1/20 0.32
FABP1 P07148 2/20 0.31
TOP1 P11387 2/20 0.31
MMP9 P14780 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174332 0.96 KDM4E (0.36) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL18590023 0.90 KDM4E (0.34) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL20174282 0.89 KDM4E (0.38) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL20174302 0.89 KDM4E (0.34) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL20174441 0.85 KDM4E (0.34) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL18590027 0.85 BACE1 (0.34) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL20174296 0.84 PDK2 (0.46) KDM4EHPGDHSD17B10MAPTALDH1A1
SCHEMBL19008361 0.83 LMNA (0.41) KDM4EHSD17B10MAPTGAABACE1
SCHEMBL20174284 0.81 PDK2 (0.39) PDK2
SCHEMBL20174318 0.81 PDK2 (0.40) KDM4EHPGDHSD17B10MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG KDM4E 3633/4885HPGD 2229/4885HSD17B10 1154/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG KDM4E 3633/4885HPGD 2229/4885HSD17B10 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.